Home
About
Publications Trends
Recent Publications
Expert Search
Archive
infectious agents
Which Infectious Agents are Linked to Cancer?
Several infectious agents have been identified as major contributors to cancer. Key examples include:
Human Papillomavirus (HPV)
: Linked to cervical cancer, anal cancer, and oropharyngeal cancers.
Hepatitis B and C Viruses (HBV and HCV)
: Associated with liver cancer.
Helicobacter pylori
: Connected to gastric cancer and MALT lymphoma.
Epstein-Barr Virus (EBV)
: Linked to Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma.
Human T-cell Leukemia Virus Type 1 (HTLV-1)
: Associated with adult T-cell leukemia/lymphoma.
Kaposi's Sarcoma-associated Herpesvirus (KSHV)
: Causes Kaposi's sarcoma and primary effusion lymphoma.
Frequently asked queries:
What are Infectious Agents?
How do Infectious Agents Cause Cancer?
Which Infectious Agents are Linked to Cancer?
What are the Risk Factors for Infection-Related Cancers?
How Can Infection-Related Cancers be Prevented?
What are the Treatment Options for Infection-Related Cancers?
How is Scalp Cooling Administered?
What role do dietary habits play in skin hydration?
How to Access SEER Data for Research Purposes?
What is the Significance of Genetic Stability in Cancer Prevention?
Can Gene Editing Be Used for Cancer Treatment?
What Role Does Big Data Play?
Who is a Candidate?
Can Prostate Cancer Be Prevented?
What Logistical Challenges Do Cancer Patients Face?
Are There Different Types of Cystoscopes?
What are the Potential Risks of Targeting Tregs?
Why Are Benefit Concerts Important for Cancer Patients?
What Role Do Patients Play in Reducing Resource Waste?
What Are the Side Effects of Methocarbamol?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe